Ramat Hasharon, Israel

Shai Novik

This inventor holds 14 USPTO granted patents and 7 published patent applications and 6 EPO patents. Top assignees: Enlivex Therapeutics Rdo Ltd, Enlivex Therapeutics Ltd, Enlivex Therapeutics R&d Ltd. Active years: 2019-2025.

USPTO Granted Patents = 14 

% Patents Active = 92.9

 

Average Co-Inventor Count = 1.8

ph-index = 4

Forward Citations = 33(Granted Patents)


Company Filing History:


Years Active: 2019-2025

Loading Chart...
Loading Chart...
14 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Shai Novik

Introduction

Shai Novik is a prominent inventor based in Ramat Hasharon, Israel, known for his significant contributions to the fields of therapeutic treatments and biotechnology. With a total of 14 patents to his name, Novik is recognized for his innovative approaches that address critical health challenges.

Latest Patents

Among his latest innovations, Novik has developed patented techniques focusing on early apoptotic cells for use in treating sepsis. These compositions aim to treat or prevent sepsis in patients by extending their survival and reducing organ dysfunction or failure. His methods involve administering early apoptotic cells or their supernatants to mitigate the proinflammatory effects associated with sepsis. Additionally, he has created methods for treating cancers using therapeutic apoptotic cells. These patents detail strategies for extending the survival of cancer patients and decreasing tumor size or growth rates, including applications in treating solid tumors and leukemia. Furthermore, his innovations also explore the preparation of inactivated early apoptotic cell populations, emphasizing their potential in cancer therapy.

Career Highlights

Shai Novik has made substantial strides in his career through his work at Enlivex Therapeutics Ltd and Enlivex Therapeutics Rdo Ltd. His involvement with these companies underscores his commitment to advancing medical research and therapeutic development, particularly in the area of cellular therapies.

Collaborations

Throughout his career, Novik has collaborated with esteemed colleagues, including Dror Mevorach, further enhancing his research endeavors. These partnerships have facilitated the growth of innovative solutions within the medical field, combining their expertise to tackle complex health issues.

Conclusion

Shai Novik's contributions to biotechnology and medical treatment underscore the importance of innovation in addressing pressing health challenges. His patents, focusing on sepsis and cancer therapy, exemplify the potential of early apoptotic cells to revolutionize treatment strategies and improve patient outcomes. As he continues to explore new avenues in research and development, Novik remains an influential figure in the landscape of modern medicine.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…